Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxis-Reference-Cited by-同舟云学术

Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxis

Published:2018-08-22 Issue:11 Volume:73 Page:3095-3101
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Muilwijk E W¹²,Maertens J A³,van der Velden W J F M⁴,ter Heine R¹,Colbers A¹^ORCID,Burger D M¹,Andes D⁵⁶,Theunissen K⁷,Blijlevens N M A⁴,Brüggemann R J M¹²

Affiliation:

1. Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Pharmacy, Nijmegen, The Netherlands

2. Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands

3. Department of Haematology, UZ Leuven, Leuven, Belgium

4. Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Haematology, Nijmegen, The Netherlands

5. Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

6. Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI, USA

7. Department of Haematology, Jessa Hospital, Hasselt, Belgium

Funder

Astellas Inc

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/11/3095/26144756/dky324.pdf

Reference43 articles.

1. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens;Corzo-Leon;Mycoses,2015

2. Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy;Neofytos;Diagn Microbiol Infect Dis,2013

3. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients;Park;J Infect,2016

4. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation;van Burik;Clin Infect Dis,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients;Pharmaceutics;2024-08-29

2. Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study;International Journal of Antimicrobial Agents;2024-01

3. Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia;Current Fungal Infection Reports;2023-07-27

4. Validation and clinical evaluation of an ultra-performance liquid chromatography with ultraviolet detector method for plasma quantification of micafungin;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2023-02-21

5. Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies;Journal of Antimicrobial Chemotherapy;2022-08-23